{"id":"celecoxib-drug","safety":{"commonSideEffects":[{"rate":"15-20","effect":"Dyspepsia"},{"rate":"10-15","effect":"Abdominal pain"},{"rate":"10-15","effect":"Diarrhea"},{"rate":"10-15","effect":"Headache"},{"rate":"5-10","effect":"Hypertension"},{"rate":"1-2","effect":"Cardiovascular events (myocardial infarction, stroke)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a selective COX-2 inhibitor, celecoxib preferentially blocks COX-2 while sparing COX-1, which is responsible for protective gastrointestinal and renal functions. This selectivity was designed to provide anti-inflammatory and analgesic effects with reduced gastrointestinal toxicity compared to non-selective NSAIDs. By inhibiting COX-2-derived prostaglandins, it reduces inflammation, pain, and fever.","oneSentence":"Celecoxib selectively inhibits cyclooxygenase-2 (COX-2), reducing the production of prostaglandins that mediate inflammation and pain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:44:49.503Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rheumatoid arthritis"},{"name":"Osteoarthritis"},{"name":"Acute pain"},{"name":"Familial adenomatous polyposis (FAP)"}]},"trialDetails":[{"nctId":"NCT07435077","phase":"PHASE4","title":"Examining Analgesic Synergy and Efficacy in Trauma Care","status":"NOT_YET_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2026-05","conditions":"Opioid Use Disorder","enrollment":282},{"nctId":"NCT07494565","phase":"PHASE2","title":"Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2026-03-05","conditions":"Diffuse Large B-Cell Lymphoma (DLBCL), CD5 Positive","enrollment":60},{"nctId":"NCT07351968","phase":"PHASE1","title":"A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee Osteoarthritis","status":"RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2026-03-10","conditions":"Moderate Pain in Knee Osteoarthritis, Severe Pain in Knee Osteoarthritis","enrollment":200},{"nctId":"NCT03818932","phase":"PHASE2, PHASE3","title":"Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2019-01-22","conditions":"Anterior Cruciate Ligament Injury","enrollment":90},{"nctId":"NCT02115074","phase":"PHASE1","title":"Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas","status":"COMPLETED","sponsor":"Centre Oscar Lambret","startDate":"2014-06","conditions":"Glioma","enrollment":20},{"nctId":"NCT04488081","phase":"PHASE2","title":"I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"QuantumLeap Healthcare Collaborative","startDate":"2020-07-31","conditions":"COVID-19","enrollment":1500},{"nctId":"NCT06231758","phase":"PHASE3","title":"Metformin Safety and Efficacy in Osteoarthritis.","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2024-01-30","conditions":"Osteo Arthritis Knee","enrollment":70},{"nctId":"NCT05343013","phase":"PHASE2","title":"TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2022-06-06","conditions":"Colorectal Cancer","enrollment":25},{"nctId":"NCT07154433","phase":"NA","title":"A Study on Reducing Opioid Use After Minimally Invasive Ankle Surgery","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-09-01","conditions":"Ankle (Ligaments); Instability (Old Injury), Ankle Sprain, Talus Osteochondral Defect","enrollment":110},{"nctId":"NCT05731726","phase":"PHASE2","title":"Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Zhejiang University","startDate":"2023-02-22","conditions":"pMMR, MSS, MSI-L","enrollment":50},{"nctId":"NCT03026140","phase":"PHASE2","title":"Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer","status":"RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2017-03-29","conditions":"Colon Carcinoma","enrollment":353},{"nctId":"NCT06671002","phase":"PHASE4","title":"Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids Trial","status":"RECRUITING","sponsor":"University of Michigan","startDate":"2025-01-10","conditions":"Surgery, Pain, Post Operative","enrollment":900},{"nctId":"NCT02574728","phase":"PHASE2","title":"Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2015-06","conditions":"Cancer","enrollment":46},{"nctId":"NCT03974932","phase":"PHASE3","title":"Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2019-06-05","conditions":"Analgesia","enrollment":116},{"nctId":"NCT06942039","phase":"EARLY_PHASE1","title":"Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation","status":"RECRUITING","sponsor":"C17 Council","startDate":"2025-09-23","conditions":"CNS Embryonal Tumor, CNS, Medulloblastoma, Atypical Teratoid Rhabdoid Tumor","enrollment":15},{"nctId":"NCT04469530","phase":"PHASE2","title":"Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors","status":"RECRUITING","sponsor":"Emory University","startDate":"2020-09-16","conditions":"Solid Tumor","enrollment":55},{"nctId":"NCT04093323","phase":"PHASE2","title":"Polarized Dendritic Cell (aDC1) Based Treatment, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma","status":"TERMINATED","sponsor":"Roswell Park Cancer Institute","startDate":"2024-11-13","conditions":"HLA-A2 Positive Cells Present, Refractory Melanoma","enrollment":1},{"nctId":"NCT01356290","phase":"PHASE2","title":"Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2014-04","conditions":"Medulloblastoma Recurrent, Ependymoma Recurrent, ATRT Recurrent","enrollment":232},{"nctId":"NCT07116564","phase":"PHASE4","title":"Impact of ERAS Protocol on Length of Hospital Stay After Laparoscopic Surgeries","status":"RECRUITING","sponsor":"Aga Khan University","startDate":"2025-08-20","conditions":"ERAS","enrollment":98},{"nctId":"NCT07414706","phase":"PHASE3","title":"Intravenous Lidocaine Plus Port-Site Ropivacaine for Recovery After Laparoscopic Surgery","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2026-03","conditions":"Intravenous Lidocaine, Laparoscopic Surgery, Post Operative Recovery","enrollment":182},{"nctId":"NCT05488847","phase":"PHASE4","title":"Opioid-Free Pain Protocol After Shoulder Arthroplasty","status":"ACTIVE_NOT_RECRUITING","sponsor":"Henry Ford Health System","startDate":"2022-06-25","conditions":"Shoulder Arthropathy, Shoulder Pain","enrollment":83},{"nctId":"NCT01881048","phase":"EARLY_PHASE1","title":"Window of Opportunity Study Targeting the Inflammatory Milieu","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2009-12-08","conditions":"Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer","enrollment":42},{"nctId":"NCT07174570","phase":"PHASE2","title":"Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer","status":"RECRUITING","sponsor":"Emory University","startDate":"2026-01-02","conditions":"Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8","enrollment":39},{"nctId":"NCT03590821","phase":"EARLY_PHASE1","title":"Timed Aspirin Chronobiome Study","status":"NOT_YET_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2027-12","conditions":"Healthy","enrollment":60},{"nctId":"NCT07353372","phase":"NA","title":"Multimodal Exercise Therapy for Non-Surgical Intervention of Nonspecific Low Back Pain.","status":"NOT_YET_RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-01-01","conditions":"Paraspinal Muscles, Low Back Pain, Machine Learning","enrollment":314},{"nctId":"NCT07338266","phase":"PHASE1","title":"Study to Assess the Safety and Pharmacokinetics of AVD275 Injection in Patients With Osteoarthritis of the Knee","status":"NOT_YET_RECRUITING","sponsor":"Avidence Therapeutics","startDate":"2026-01","conditions":"Osteoarthritis of the Knee","enrollment":15},{"nctId":"NCT07344246","phase":"NA","title":"Efficacy and Safety of Intravenous Dexamethasone Palmitate Treatments in Acute and Subacute Herpes Zoster Pain","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-02-01","conditions":"Herpes Zoster Pain","enrollment":954},{"nctId":"NCT07076069","phase":"PHASE4","title":"The Effect of Multimodal Pain Regimen on Use of Narcotics After Rotator Cuff Tear Repair","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2025-07-21","conditions":"Rotator Cuff Repairs, Pain Management","enrollment":130},{"nctId":"NCT06076837","phase":"PHASE1","title":"The Seven Trial: Exploiting the Unfolded Protein Response","status":"ACTIVE_NOT_RECRUITING","sponsor":"HonorHealth Research Institute","startDate":"2025-01-09","conditions":"Pancreatic Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic","enrollment":6},{"nctId":"NCT02171104","phase":"PHASE2","title":"MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2014-07-10","conditions":"Mucopolysaccharidosis Disorders, Hurler Syndrome, Hunter Syndrome","enrollment":149},{"nctId":"NCT05603832","phase":"PHASE3","title":"A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement","status":"COMPLETED","sponsor":"Arthritis Innovation Corporation","startDate":"2022-11-17","conditions":"Post Operative Pain","enrollment":151},{"nctId":"NCT05077332","phase":"PHASE2","title":"LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)","status":"COMPLETED","sponsor":"Leidos Life Sciences","startDate":"2021-12-29","conditions":"2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease","enrollment":4},{"nctId":"NCT07176533","phase":"NA","title":"Suprazygomatic Maxillary Nerve Block in Pediatric Tonsillectomy","status":"NOT_YET_RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2026-01-01","conditions":"Tonsillitis","enrollment":60},{"nctId":"NCT07246278","phase":"PHASE1, PHASE2","title":"Celecoxib in Parkinson Disease as Adjuvant Therapy","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-11-20","conditions":"Parkinson Disease","enrollment":80},{"nctId":"NCT06505187","phase":"PHASE2","title":"Celecoxib for ENT Pain Management","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2025-02-28","conditions":"Parotidectomy","enrollment":84},{"nctId":"NCT07257133","phase":"PHASE4","title":"A Study Of Opioid Avoidance In Surgery Through Integrating Suzetrigine","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-03","conditions":"Post Operative Pain","enrollment":40},{"nctId":"NCT04860635","phase":"PHASE2, PHASE3","title":"Safety of F14 Following Total Knee Replacement","status":"SUSPENDED","sponsor":"Arthritis Innovation Corporation","startDate":"2026-09","conditions":"Analgesia","enrollment":100},{"nctId":"NCT03926338","phase":"PHASE2","title":"Neoadjuvant Toripalimab With or Without Celecoxib in dMMR/MSI-H Colorectal Cancer","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2019-05-10","conditions":"Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H)","enrollment":270},{"nctId":"NCT07171034","phase":"PHASE1","title":"A Phase I Study of KLA318-2 Nanocrystal Injection","status":"RECRUITING","sponsor":"Hunan Kelun Pharmaceutical Co., Ltd.","startDate":"2025-09-01","conditions":"Healthy Participants","enrollment":48},{"nctId":"NCT04786548","phase":"PHASE2","title":"Neuroinflammation in Patients With OCD","status":"SUSPENDED","sponsor":"New York State Psychiatric Institute","startDate":"2021-04-01","conditions":"Obsessive-Compulsive Disorder","enrollment":21},{"nctId":"NCT07221019","phase":"PHASE4","title":"Single Shot Exparel vs Catheters in Lower Extremity Trauma","status":"RECRUITING","sponsor":"George Washington University","startDate":"2025-09-12","conditions":"Fracture Dislocation of Ankle Joint, Fracture Leg, Fracture Femur","enrollment":90},{"nctId":"NCT05722002","phase":"PHASE4","title":"Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial","status":"RECRUITING","sponsor":"University of Michigan","startDate":"2023-02-06","conditions":"Surgery, Pain, Postoperative","enrollment":900},{"nctId":"NCT05215236","phase":"NA","title":"Opiate Sparing Protocol Randomized Controlled Trial in Open Distal Radius Fracture Repair","status":"COMPLETED","sponsor":"Campbell Clinic","startDate":"2022-03-01","conditions":"Distal Radius Fracture","enrollment":72},{"nctId":"NCT05415397","phase":"PHASE3","title":"Treating Immuno-metabolic Depression With Anti-inflammatory Drugs","status":"RECRUITING","sponsor":"Amsterdam UMC, location VUmc","startDate":"2022-09-28","conditions":"Depressive Disorder, Major, Inflammation","enrollment":140},{"nctId":"NCT03912428","phase":"PHASE1","title":"Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal Conditions","status":"TERMINATED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2019-06-14","conditions":"Myositis, Inflammatory, Rheumatoid Arthritis","enrollment":31},{"nctId":"NCT06344403","phase":"NA","title":"Clinical Efficacy and Safety of Tender Point Infiltration (TPI) for Acute and Subacute Zoster Associated Pain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-06-01","conditions":"Herpes Zoster, Local Infiltration, Acute Pain","enrollment":136},{"nctId":"NCT05357950","phase":"PHASE2","title":"A Phase IIb, Multi-Center, Multinational, Double-Blind, Placebo-Controlled Study, With an Open Label Extension, to Evaluate Safety, Tolerability and Efficacy of PrimeC in Subjects With ALS","status":"COMPLETED","sponsor":"NeuroSense Therapeutics Ltd.","startDate":"2022-05-31","conditions":"Amyotrophic Lateral Sclerosis, ALS","enrollment":69},{"nctId":"NCT07154316","phase":"PHASE2","title":"Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Fudan University","startDate":"2025-08-01","conditions":"Colorectal Cancer","enrollment":138},{"nctId":"NCT07150949","phase":"PHASE2","title":"Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC)","status":"RECRUITING","sponsor":"Fudan University","startDate":"2025-08-28","conditions":"Locally Advanced Rectal Cancer, Neoadjuvant Therapy","enrollment":138},{"nctId":"NCT04814355","phase":"PHASE4","title":"The Effect of Celecoxib on Neuroinflammation in MDD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stony Brook University","startDate":"2018-08-01","conditions":"Major Depressive Disorder, Neuroinflammation","enrollment":42},{"nctId":"NCT07139405","phase":"PHASE2","title":"TRIGLYTZA® VERSUS METFORMIN IN OBESE ADULT TYPE 2 DIABETES (T2DM) PATIENTS OVER 24 WEEKS OF TREATMENT","status":"NOT_YET_RECRUITING","sponsor":"Myopharm Limited","startDate":"2026-02","conditions":"Type 2 Diabetes (T2DM)","enrollment":90},{"nctId":"NCT04562610","phase":"PHASE2, PHASE3","title":"Enhanced Recovery After Surgery in Orthopaedic Spine Surgery","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2020-11-18","conditions":"Lumbar Surgery","enrollment":33},{"nctId":"NCT04115098","phase":"PHASE2","title":"Individualizing Anti-Inflammatory Medications for Adults With Axial Spondyloarthritis: A Series of N-of 1 Trials","status":"TERMINATED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-06-25","conditions":"Axial Spondyloarthritis","enrollment":42},{"nctId":"NCT05962957","phase":"PHASE2","title":"Role of Pentoxifylline and Celecoxib in Parkinsonism","status":"COMPLETED","sponsor":"Mostafa Bahaa","startDate":"2023-08-07","conditions":"Parkinson Disease","enrollment":80},{"nctId":"NCT05658887","phase":"PHASE4","title":"Preoperative Gabapentin vs Placebo for Vaginal Prolapse Surgery","status":"COMPLETED","sponsor":"Joseph Kowalski","startDate":"2023-01-01","conditions":"Pelvic Organ Prolapse, Perioperative/Postoperative Complications","enrollment":110},{"nctId":"NCT06159114","phase":"PHASE4","title":"Efficacy and Safety of Ningmitai Capsule Alone or Combined With Celecoxib in the Treatment of CP/CPPS","status":"COMPLETED","sponsor":"Xintian Pharmaceutical","startDate":"2023-12-19","conditions":"Chronic Prostatitis","enrollment":246},{"nctId":"NCT07104266","phase":"PHASE2","title":"Triple Negative Breast Cancer and Celecoxib. Pilot Study","status":"RECRUITING","sponsor":"Université de Sherbrooke","startDate":"2025-08-04","conditions":"Triple-Negative Breast Cancer","enrollment":30},{"nctId":"NCT05017246","phase":"PHASE2","title":"Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2022-01-18","conditions":"Cancer Debulking, Enlarged Uterus, Fibroid Uterus","enrollment":110},{"nctId":"NCT07093827","phase":"","title":"A Prospective Cohort Study on the Effect of Spinal Spinal Cord Injury on Sexual Function in Male Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2020-01-01","conditions":"Sexual Function Abnormal, Spinal Cord Injuries (SCI)","enrollment":1600},{"nctId":"NCT02885974","phase":"PHASE1","title":"Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2016-12","conditions":"Bladder Cancer","enrollment":22},{"nctId":"NCT06699966","phase":"PHASE4","title":"Stony Brook Medicine Anti-Inflammatory Trial","status":"NOT_YET_RECRUITING","sponsor":"Stony Brook University","startDate":"2026-01","conditions":"Major Depressive Disorder","enrollment":42},{"nctId":"NCT06245109","phase":"PHASE4","title":"Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2024-02-26","conditions":"Knee Osteoarthritis","enrollment":180},{"nctId":"NCT06938581","phase":"NA","title":"ERAS Protocols in Breast Conserving Surgery","status":"RECRUITING","sponsor":"University of Nebraska","startDate":"2025-07-11","conditions":"Breast Cancer, Postoperative Recovery","enrollment":260},{"nctId":"NCT04767841","phase":"PHASE1, PHASE2","title":"The AMPK Modulator Metformin as a Novel Adjunct to Conventional Therapy in Patients With Knee Osteoarthritis","status":"WITHDRAWN","sponsor":"Sadat City University","startDate":"2021-02-16","conditions":"Osteo Arthritis Knee","enrollment":""},{"nctId":"NCT04789837","phase":"PHASE1, PHASE2","title":"The Phosphodiesterase 3 Inhibitor Cilostazol as an Adjunct to Conventional Therapy in Patients With Osteoarthritis","status":"WITHDRAWN","sponsor":"Sadat City University","startDate":"2021-03-01","conditions":"Osteoarthritis","enrollment":""},{"nctId":"NCT06997068","phase":"PHASE2","title":"Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Oral Cavity Cancer in a Rural Midwest United States Population","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-07-09","conditions":"Metastatic Oral Cavity Carcinoma, Recurrent Oral Cavity Carcinoma, Stage IVC Lip and Oral Cavity Cancer AJCC v8","enrollment":25},{"nctId":"NCT07049185","phase":"PHASE2","title":"QL1706 Plus Celecoxib in Advanced Esophageal Squamous Cell Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Peking University Cancer Hospital & Institute","startDate":"2025-07-15","conditions":"Esophageal Squamous Cell Carcinoma","enrollment":35},{"nctId":"NCT07032883","phase":"NA","title":"Benson Relaxation Technique Effectiveness on Pain and Quality of Life Post Reconstructive Mammoplasty","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2025-06-25","conditions":"Breast Cancer","enrollment":68},{"nctId":"NCT05756166","phase":"PHASE1, PHASE2","title":"Rintatolimod, Celecoxib and Interferon Alpha 2b With Pembrolizumab For the Treatment of Patients With Metastatic or Unresectable Triple Negative Breast Cancer","status":"TERMINATED","sponsor":"Roswell Park Cancer Institute","startDate":"2024-02-16","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast Carcinoma","enrollment":5},{"nctId":"NCT04413799","phase":"EARLY_PHASE1","title":"PVB vs Ketamine/Lidocaine in Rib Fracture Patients","status":"TERMINATED","sponsor":"George Washington University","startDate":"2020-09-01","conditions":"Rib Fractures, Rib Trauma, Rib Fracture Multiple","enrollment":32},{"nctId":"NCT03686657","phase":"PHASE1, PHASE2","title":"Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients","status":"NOT_YET_RECRUITING","sponsor":"ARKAY Therapeutics","startDate":"2025-10-10","conditions":"Type 2 Diabetes, High Blood Pressure, Arthritis","enrollment":115},{"nctId":"NCT05965492","phase":"PHASE3","title":"Multimodal Pain Package vs. Regular Formulation for Pain Management in Ambulatory Spinal Surgery","status":"WITHDRAWN","sponsor":"University of Miami","startDate":"2024-06-01","conditions":"Spinal Disorder","enrollment":""},{"nctId":"NCT06722534","phase":"NA","title":"Celecoxib for Prevention of Progression in Peutz-Jeghers Syndrome","status":"RECRUITING","sponsor":"Air Force Military Medical University, China","startDate":"2025-02-01","conditions":"Peutz-Jeghers Syndrome, Celecoxib, Small Bowel Polyp","enrollment":80},{"nctId":"NCT06379425","phase":"PHASE4","title":"Impact of Preoperative Opioid-free Multimodal Analgesia on Time to Trial of Void in Ambulatory Urogynecologic Surgeries","status":"RECRUITING","sponsor":"Northwell Health","startDate":"2024-03-01","conditions":"Pain, Postoperative, Postoperative Pain, Acute","enrollment":70},{"nctId":"NCT03710876","phase":"PHASE3","title":"Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ferring Ventures Limited","startDate":"2019-01-21","conditions":"Malignant Pleural Mesothelioma","enrollment":53},{"nctId":"NCT06967363","phase":"","title":"Multimodal Imaging and Biospecimen Collection for Low Back Pain (LBPB)","status":"NOT_YET_RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2025-05-15","conditions":"Chronic Low Back Pain (CLBP), Acute Low Back Pain, Low Back Pain","enrollment":360},{"nctId":"NCT06946979","phase":"NA","title":"Clinical Study on the Use of Massage to Reconstruct the Function of Lumbar Stabilizer Muscles and Improve the \"Muscle and Bone Imbalance\" of Lumbar Disc Herniation","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Zhejiang Chinese Medical University","startDate":"2025-04-30","conditions":"Lumbar Disc Herniation","enrollment":96},{"nctId":"NCT06916000","phase":"NA","title":"Assessment of PENG Block as a Part of Multimodal Analgesia Following Hip Surgeries.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ain Shams University","startDate":"2024-06-27","conditions":"Anesthesia","enrollment":50},{"nctId":"NCT06516094","phase":"PHASE3","title":"Efficacy and Safety in the Combination of Celecoxib / Pregabalin / Vitamin B for Low Back Chronic Pain","status":"COMPLETED","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"2024-04-11","conditions":"Chronic Low-back Pain","enrollment":192},{"nctId":"NCT06863636","phase":"PHASE3","title":"Efficacy and Safety of Celecoxib/Acetaminophen Versus Celecoxib for Diagnosed Osteoarthritis in Acute Exacerbation","status":"RECRUITING","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"2024-09-09","conditions":"Joint Pain, Knee Osteoarthritis, Hip Osteoarthritis","enrollment":231},{"nctId":"NCT06903858","phase":"PHASE2","title":"Neoadjuvant Toripalimab Plus Celecoxib for dMMR/MSI-H Locally Advanced Colorectal Cancer","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-04-01","conditions":"Colorectal Cancer (CRC), PD-1 Inhibitor, Neoadjuvant Immunotherapy","enrollment":105},{"nctId":"NCT05050409","phase":"NA","title":"SMART Embedded Intervention for Military Postsurgical Engagement Readiness","status":"RECRUITING","sponsor":"University of Utah","startDate":"2022-05-01","conditions":"Knee Pain Chronic","enrollment":500},{"nctId":"NCT06340932","phase":"","title":"Impact of Opioid Avoidance Protocol for ACL Reconstruction","status":"COMPLETED","sponsor":"Matthew Varacallo","startDate":"2024-04-27","conditions":"ACL Tear, Post Operative Pain","enrollment":32},{"nctId":"NCT02030964","phase":"PHASE1","title":"N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan","status":"COMPLETED","sponsor":"New Approaches to Neuroblastoma Therapy Consortium","startDate":"2014-01-16","conditions":"Neuroblastoma","enrollment":30},{"nctId":"NCT04041050","phase":"PHASE1","title":"A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2019-11-08","conditions":"Myeloproliferative Neoplasm","enrollment":85},{"nctId":"NCT05974501","phase":"PHASE4","title":"Pre vs Post Block in Total Knee Arthroplasty (TKA)","status":"COMPLETED","sponsor":"University of Miami","startDate":"2023-09-29","conditions":"Knee Osteoarthritis, Arthroplasty Complications, Postoperative Pain","enrollment":84},{"nctId":"NCT04162873","phase":"PHASE2","title":"Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer","status":"TERMINATED","sponsor":"University of Utah","startDate":"2019-11-27","conditions":"Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Nasal Cavity and Paranasal Sinus Carcinoma","enrollment":13},{"nctId":"NCT06603051","phase":"NA","title":"The Effect of Pre-Operative Cryoneurolysis on Post-Operative Narcotic Consumption in Patients Undergoing Autograft ACL Reconstruction","status":"RECRUITING","sponsor":"Virtua Health, Inc.","startDate":"2024-08-28","conditions":"ACL Repair","enrollment":20},{"nctId":"NCT06316843","phase":"PHASE2","title":"Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2","status":"COMPLETED","sponsor":"Bateman Horne Center","startDate":"2023-10-15","conditions":"Long COVID, PASC Post Acute Sequelae of COVID 19","enrollment":59},{"nctId":"NCT03337607","phase":"NA","title":"Radial Extracorporeal Shock Wave Therapy for Chronic Non-specific Low Back Pain","status":"COMPLETED","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2017-11-13","conditions":"Low Back Pain","enrollment":150},{"nctId":"NCT03090152","phase":"PHASE4","title":"Minimal Opioid Use After Total Hip Replacement (THR)","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2017-03-08","conditions":"Osteoarthritis, Hip","enrollment":180},{"nctId":"NCT03084536","phase":"PHASE2","title":"PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2017-06-07","conditions":"Breast Cancer, Breast Cancer Female, Cancer of Breast","enrollment":134},{"nctId":"NCT05281276","phase":"PHASE1","title":"Chidamide + Celecoxib in Advanced Metastatic Colorectal Cancer (CCmCC)","status":"TERMINATED","sponsor":"Taipei Medical University Shuang Ho Hospital","startDate":"2022-09-20","conditions":"Metastatic Colorectal Cancer","enrollment":9},{"nctId":"NCT03643744","phase":"PHASE1","title":"Photodynamic Therapy-Induced Immune Modulation: Part III","status":"TERMINATED","sponsor":"Wright State University","startDate":"2019-04-01","conditions":"Actinic Keratosis, Photodynamic Therapy","enrollment":12},{"nctId":"NCT06602167","phase":"NA","title":"Electroacupuncture Combined With Self-administered Acupressure for the Prevention of Capecitabine-Associated Hand-Foot Syndrome","status":"RECRUITING","sponsor":"Affiliated Hospital of Qinghai University","startDate":"2024-10-08","conditions":"Capecitabine, Hand-foot Syndrome, Electroacupuncture","enrollment":220},{"nctId":"NCT02993029","phase":"NA","title":"99Tc-MDP Treatment for Knee Osteoarthritis","status":"RECRUITING","sponsor":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2017-09-01","conditions":"Treatment Outcome","enrollment":40},{"nctId":"NCT04176419","phase":"PHASE3","title":"Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery","status":"TERMINATED","sponsor":"Case Comprehensive Cancer Center","startDate":"2020-01-17","conditions":"Postoperative Pain Control, Opioid Consumption","enrollment":30},{"nctId":"NCT04147013","phase":"PHASE4","title":"Effect of Celecoxib on Postoperative Analgesia and Disease Severity in AERD Patients with CRS","status":"ACTIVE_NOT_RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2020-02-18","conditions":"Chronic Rhinosinusitis with Nasal Polyps, Aspirin-exacerbated Respiratory Disease","enrollment":44},{"nctId":"NCT04765644","phase":"PHASE4","title":"Arginine Supplementation to Improve Cardiovascular and Endothelial Function After NSAID Treatment","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2021-06-10","conditions":"Healthy","enrollment":44},{"nctId":"NCT05644301","phase":"PHASE3","title":"INflammation-based Stratification for Immune-Targeted Augmentation in Major Depressive Disorder","status":"RECRUITING","sponsor":"Universiteit Antwerpen","startDate":"2023-09-21","conditions":"Major Depressive Disorder, Inflammation","enrollment":240}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":13,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Celebrex"],"phase":"phase_3","status":"active","brandName":"Celecoxib(drug)","genericName":"Celecoxib(drug)","companyName":"Chinese University of Hong Kong","companyId":"chinese-university-of-hong-kong","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Celecoxib selectively inhibits cyclooxygenase-2 (COX-2), reducing the production of prostaglandins that mediate inflammation and pain. Used for Rheumatoid arthritis, Osteoarthritis, Acute pain.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}